ArticleBMC cancer2023

Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma.

Zuyi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.